Molecular Endocrinology, Vol 9, 1202-1213, Copyright © 1995 by Endocrine Society

ARTICLES

N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone

L Ng, D Forrest, BR Haugen, WM Wood and T Curran
Roche Institute of Molecular Biology, Nutley, New Jersey 07110, USA.

The human syndrome of resistance to thyroid hormone (RTH) is associated with dominant mutations in the thyroid hormone receptor beta (TR beta) gene that generate mutant receptors with impaired binding for T3. Although the TR beta gene differentially expresses two N-terminal variant receptors, TR beta 1 and TR beta 2, functional analyses of RTH mutants have focused exclusively on TR beta 1. Since TR beta 2 is expressed in tissues that are malfunctional in RTH, the role of mutations in the context of TR beta 2 was examined. We compared the functional properties of corresponding RTH mutations in the common C- terminal domain of both TR beta 1 and TR beta 2. Wild type TR beta 1 and TR beta 2 bound similarly as homodimers and as heterodimers with retinoid X receptors to T3-responsive elements consisting of a direct repeat with 4-base pair spacing or an everted repeat. Homodimers, but not monomers or heterodimers, of both receptor subtypes were dissociated by the addition of T3. However, TR beta 2 formed at least 10-fold more stable homodimers than TR beta 1 on a palindromic repeat element, indicating that the N termini of TR beta 1 and TR beta 2 differentially influence dimerization on DNA. The RTH-like mutants of both TR beta 1 and TR beta 2 were equally insensitive to T3. They were defective in T3 binding but still bound DNA like their wild type counterparts except that the T3-dependent dissociation of homodimers from DNA was severely reduced. Wild type TR beta 1 and TR beta 2 mediated T3-inducible transactivation in cotransfection assays; this, however, was abolished in both mutants. TR beta 1 mediated more sensitive T3-dependent transcriptional suppression than TR beta 2 through the negative T3 response region of the TSH beta gene. Again, the mutation abolished T3-dependent suppression by both mutants. Furthermore, both mutants inhibited T3-inducible transcriptional activation by different wild type TR alpha and beta variants. These results indicate that both mutants have the potential to contribute to the pathogenesis of RTH and suggest that a reassessment of previous models of RTH is required to take into account the inhibitory activity of both TR beta 2 and TR beta 1 mutants.

This article has been cited by other articles:

				F. Flamant, K. Gauthier, and J. Samarut Thyroid Hormones Signaling Is Getting More Complex: STORMs Are Coming Mol. Endocrinol., February 1, 2007; 21(2): 321 - 333. [Abstract] [Full Text] [PDF]

				M. Srinivas, L. Ng, H. Liu, L. Jia, and D. Forrest Activation of the Blue Opsin Gene in Cone Photoreceptor Development by Retinoid-Related Orphan Receptor {beta} Mol. Endocrinol., August 1, 2006; 20(8): 1728 - 1741. [Abstract] [Full Text] [PDF]

				W. Wan, B. Farboud, and M. L. Privalsky Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542. [Abstract] [Full Text] [PDF]

				A. Campos-Barros, L. L. Amma, J. S. Faris, R. Shailam, M. W. Kelley, and D. Forrest Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing PNAS, February 1, 2000; 97(3): 1287 - 1292. [Abstract] [Full Text] [PDF]

				S. Göthe, Z. Wang, L. Ng, J. M. Kindblom, A. C. Barros, C. Ohlsson, B. Vennström, and D. Forrest Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation Genes & Dev., May 15, 1999; 13(10): 1329 - 1341. [Abstract] [Full Text]

				M.-F. Langlois, K. Zanger, T. Monden, J. D. Safer, A. N. Hollenberg, and F. E. Wondisford A Unique Role of the beta -2 Thyroid Hormone Receptor Isoform in Negative Regulation by Thyroid Hormone. MAPPING OF A NOVEL AMINO-TERMINAL DOMAIN IMPORTANT FOR LIGAND-INDEPENDENT ACTIVATION J. Biol. Chem., October 3, 1997; 272(40): 24927 - 24933. [Abstract] [Full Text] [PDF]

				R. E. Weiss, D. Forrest, J. Pohlenz, K. Cua, T. Curran, and S. Refetoff Thyrotropin Regulation by Thyroid Hormone in Thyroid Hormone Receptor {beta}-Deficient Mice Endocrinology, September 1, 1997; 138(9): 3624 - 3629. [Abstract] [Full Text] [PDF]

				S. G. Ball, M. Ikeda, and W. W. Chin Deletion of the Thyroid Hormone {beta}1 Receptor Increases Basal and Triiodothyronine-Induced Growth Hormone Messenger Ribonucleic Acid in GH3 Cells Endocrinology, August 1, 1997; 138(8): 3125 - 3132. [Abstract] [Full Text] [PDF]

				J. D. Safer, M. F. Langlois, R. Cohen, T. Monden, D. John-Hope, J. Madura, A. N. Hollenberg, and F. E. Wondisford Isoform Variable Action among Thyroid Hormone Receptor Mutants Provides Insight into Pituitary Resistance to Thyroid Hormone Mol. Endocrinol., January 1, 1997; 11(1): 16 - 26. [Abstract] [Full Text]

				T. Satoh, M. Yamada, T. Iwasaki, and M. Mori Negative Regulation of the Gene for the Preprothyrotropin-releasing Hormone from the Mouse by Thyroid Hormone Requires Additional Factors in Conjunction with Thyroid Hormone Receptors J. Biol. Chem., November 1, 1996; 271(44): 27919 - 27926. [Abstract] [Full Text] [PDF]